BRITTANY CHANDLER: Open Payments
NPI 1184285108 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$744 in 30 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $223 · 2025 $744
Food & beverage: $632Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $292 |
| E.R. Squibb & Sons, L.L.C. | 11 | $200 |
| ABBVIE INC. | 5 | $92 |
| Otsuka America Pharmaceutical, Inc. | 4 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Tris Pharma Inc | 1 | $14 |
Products named: COBENFY, UZEDY, VRAYLAR, REXULTI, ABILIFY MAINTENA, TRINTELLIX, Qelbree, Auvelity.
Industry payments across VA — which companies pay providers there.
